Journal of Microencapsulation · 2021 · 22 citations · 48 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryNanoparticle Drug DeliveryPharmacodynamicsDrug EncapsulationNanomaterials For Drug DeliveryNanoparticle Delivery SystemsNanoparticle DesignNanoparticle FormulationsTopical PreparationsAnti-inflammatory ActivityBox-behnken DesignsLipid Nanoparticle CharacterizationLipid NanoparticlesLipid-based Nanoparticle FormulationSolid Lipid Nanoparticle EncapsulationTopical Anti-inflammatory PreparationsTopical Anti-inflammatory Therapy
This work aimed to elaborate an optimised fluticasone propionate (FP)–loaded solid lipid nanoparticles (SLNs) to enhance FP effectiveness for topical inflammatory remediation. The influences of drug amount, lipid, and surfactant ratios, on drug release pattern and stability were investigated utilising Box-Behnken design. Elaboration, characterisation, and pharmacodynamic evaluation in comparison with the marketed formulation (Cutivate® cream, 0.05%w/w FP), were conducted for the optimised SLNs. The optimised SLNs with a size of 248.3 ± 1.89 nm (PDI = 0.275) and −32.4 ± 2.85 mV zeta potential were evidenced good stability physiognomies. The optimised SLNs pre-treated rats exhibited non-significant difference in paw volume from that of the control group and showed a significant reduction in both PGE2 and TNF-α levels by 51.5 and 61%, respectively, in comparison with the Carrageenan group. The optimised FP–loaded SLNs maximised the efficacy of FP towards inflammation alleviation that increase its potential as efficient implement in inflammatory skin diseases remediation.
48
Nanoparticles: Emerging carriers for drug delivery
Sagar R. Mudshinge, Amol Bhalchandra Deore, S. R. Patil et al. · Saudi Pharmaceutical Journal · 2011 · 536 citations · Full text